SCHEMBL31222697

SCHEMBL31222697

COC(=O)c1ccc(-c2ccccc2)c(OC)c1

nearest known ligand 0.61

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
EGFR P00533 2/20 0.61
PTGS2 P35354 1/20 0.58
MAPT P10636 1/20 0.55
MKNK1 Q9BUB5 1/20 0.52
MKNK2 Q9HBH9 1/20 0.52
TSHR P16473 1/20 0.52
KMT2A Q03164 3/20 0.51
ALDH1A1 P00352 1/20 0.51
LMNA P02545 1/20 0.51
ROCK2 O75116 2/20 0.49
ROCK1 Q13464 2/20 0.49
RAB9A P51151 2/20 0.49
PYGL P06737 1/20 0.48
MEN1 O00255 1/20 0.48
ABCC1 P33527 1/20 0.48
NPC1 O15118 1/20 0.48
HCRTR1 O43613 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31238859 0.90 MAPT (0.58) EGFRPTGS2MAPTMKNK1MKNK2
SCHEMBL35823 0.87 PTGS2 (0.58) EGFRPTGS2MAPTTSHRKMT2A
SCHEMBL2039468 0.87 CA12 (0.62) EGFRMKNK1MKNK2TSHRKMT2A
SCHEMBL29473817 0.87 CA12 (0.62) EGFRMKNK1MKNK2TSHRKMT2A
SCHEMBL31238850 0.86 MAPT (0.66) MAPTTSHRKMT2AALDH1A1LMNA
SCHEMBL13066266 0.86 ALDH1A1 (0.58) EGFRPTGS2MAPTKMT2AALDH1A1
SCHEMBL10296036 0.85 MKNK1 (0.54) EGFRMAPTMKNK1MKNK2KMT2A
SCHEMBL6535961 0.85 MAPT (0.57) EGFRMAPTTSHRKMT2AALDH1A1
SCHEMBL10458005 0.85 PTGS2 (0.76) EGFRPTGS2MAPTTSHRKMT2A
SCHEMBL17630101 0.84 MAPT (0.53) EGFRPTGS2MAPTKMT2AROCK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122029148-A N-phenyl-3- (2, 5-dioxopyrrolidin-1-yl) propionamide derivatives and similar compounds as DUX4 inhibitors for the treatment of, for example, neuromuscular diseases 阿勒泰治疗公司 2026-05-12 CN disclosed
CN-119013017-A Pharmaceutical composition for treating cancer comprising an anticancer agent and a novel compound having an inhibitory activity on prostaglandin E2 receptor 治纳辅医药科技有限公司 2024-11-22 CN disclosed